Healthcare Press Releases

DISC Surgery Center at Newport Beach ("DISC") has deepened its partnership with Blue Shield of California ("Blue Shield") to both advance and increase access to leading-edge spine care in the outpatient setting.Announcement is the result of a thoughtful and swift negotiation. DISC, through parent company TriasMD, was one of the first surgery centers in California to work directly with Blue Shield in 2023 to establish a new and expansive contract.

PENTAX Medical Americas, a division of HOYA Group, is excited to announce that it has obtained CE marks, clearing it for commercialization in the European Union for two of its latest innovations: the PENTAX Medical INSPIRA™ premium video processor and the i20c video endoscope series.

Children's Minnesota is thrilled to announce it is the first health system in North America to open a pediatric hybrid intraoperative magnetic resonance imaging (iMRI) suite equipped with both moving-scanner and moving-patient MRI technology in the same surgical space.

Co-Diagnostics, Inc.a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it has commenced clinical evaluations for its at-home and point-of-care Co-Dx PCR

Hologic Inc. (Nasdaq: HOLX), a global leader in women's health, has announced approval of the NovaSure® V5 global endometrial ablation (GEA) device in Canada and Europe.

Tasso, Inc., the leading provider of patient-centric, clinical-grade blood collection solutions, announced that the TassoOne™ Plus, a new high-volume liquid blood collection device, has received CE Mark certification and successfully fulfilled all of the performance,safety, and relevant product requirements.

Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft®, an innovative non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults, announces the issuance of 3 new patents in the United States.

LivaNova announces limited commercial release of Essenz Perfusion System for cardiopulmonary bypass procedures in select European centers. The system includes a next-gen heart-lung machine and a patient monitor that provides data-driven decisions during life-saving CPB procedures.

BD,a leading global medical technology company, had announced that it has received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV) to help combat illness in the current and future respiratory virus seasons.

Preeclampsia Foundation Canada opens applications for 2023 Vision Grant program, announced at SMFM's.